Idera Pharmaceuticals, Inc. (IDRA)
(Delayed Data from NSDQ)
$3.57 USD
+0.51 (16.67%)
Updated May 3, 2019 04:00 PM ET
After-Market: $3.56 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For IDRA
-
Idera: Q3 Earnings Snapshot
-
Idera Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
-
Idera Pharmaceuticals Reports Second Quarter 2022 Financial Results
-
Idera Pharmaceuticals (IDRA) Reports Q2 Loss, Tops Revenue Estimates
-
Idera Pharmaceuticals (IDRA) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
-
Idera Pharmaceuticals (IDRA) Reports Q1 Loss, Lags Revenue Estimates
-
Will Idera Pharmaceuticals (IDRA) Report Negative Q1 Earnings? What You Should Know
-
Idera Pharmaceuticals (IDRA) Reports Q3 Loss, Lags Revenue Estimates
-
Idera Pharmaceuticals (IDRA) Q3 Earnings Preview: What to Expect
-
Idera Pharmaceuticals (IDRA) Reports Q2 Loss, Lags Revenue Estimates
-
Why Idera Pharmaceuticals (IDRA) Could Be Positioned for a Surge